AKT1 and cancer: And these anti-cancer activities involves ROS regulation (Xie et al., 2019), phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway (Lai et al., 2017), JAK-STAT signaling pathway (Wang et al., 2019), and so on.